Save information for later
Sign Up

Learn About Lymphofollicular Hyperplasia

What is the definition of Lymphofollicular Hyperplasia?

Lymphofollicular hyperplasia is an increase in the number of cells found in lymph node. These follicles contain normal white blood cells called lymphocytes. Your body produces more lymphocytes to help prevent bacteria, viruses, and other types of germs from entering the bloodstream. This may or may not be normal depending on why it occurs.

What are the alternative names for Lymphofollicular Hyperplasia?

Lymphadenopathy; Lymphofollicular hypertrophy

Who are the top Lymphofollicular Hyperplasia Local Doctors?
Alberto Briganti
Elite in Lymphofollicular Hyperplasia
Elite in Lymphofollicular Hyperplasia
Milan, IT 

Alberto Briganti practices in Milan, Italy. Mr. Briganti is rated as an Elite expert by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Prostate Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Cystectomy.

Francesco Montorsi
Elite in Lymphofollicular Hyperplasia
Elite in Lymphofollicular Hyperplasia
Milan, IT 

Francesco Montorsi practices in Milan, Italy. Mr. Montorsi is rated as an Elite expert by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Prostate Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Cystectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Mamiko Yanagimoto-Sakata
Elite in Lymphofollicular Hyperplasia
Elite in Lymphofollicular Hyperplasia
Tsukuba, JP 

Mamiko Yanagimoto-Sakata practices in Tsukuba, Japan. Ms. Yanagimoto-Sakata is rated as an Elite expert by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Bone Marrow Transplant, and Bone Graft.

What are the latest Lymphofollicular Hyperplasia Clinical Trials?
Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, Lymphomas, or Histiocytic/Dendritic Cell Neoplasms

Summary: This phase I trial studies the best dose and side effects of the VSV-hIFNβ-NIS vaccine with or without cyclophosphamide and combinations of ipilimumab, nivolumab, and cemiplimab in treating patients with multiple myeloma, acute myeloid leukemia or lymphoma that has come back after a period of improvement (relapsed) or that does not respond to treatment (refractory). VSV-IFNβ-NIS is a modified vers...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1a/1b Trial in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma to Determine the Safety Profile, Pharmacology, and Maximum Tolerated Dose of ST-001, a Fenretinide Phospholipid Suspension (12.5 mg/mL) for Intravenous Infusion

Summary: This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL).

What are the Latest Advances for Lymphofollicular Hyperplasia?
Syphilis: A Review.
Secondary syphilis.
Tired of the same old research?
Check Latest Advances
Who are the sources who wrote this article ?

Published Date: August 26, 2023
Published By: Jatin M. Vyas, MD, PhD, Roy and Diana Vagelos Professor in Medicine, Columbia University Vagelos College of Physicians and Surgeons, Division of Infectious Diseases, Department of Medicine, New York, NY. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Winter JN. Approach to the patient with lymphadenopathy or splenomegaly. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 154.